The spectrum of intermediate SCN8A-related epilepsy.
Anticonvulsants
/ therapeutic use
Ataxia
/ genetics
Child
Child, Preschool
Cognitive Dysfunction
/ genetics
Electroencephalography
Epilepsy
/ drug therapy
Genetic Testing
High-Throughput Nucleotide Sequencing
Humans
Infant
Intellectual Disability
/ genetics
Language Development Disorders
/ genetics
Movement Disorders
/ genetics
Muscle Hypotonia
/ genetics
Mutation, Missense
NAV1.6 Voltage-Gated Sodium Channel
/ genetics
Pedigree
Severity of Illness Index
SCN8A
epilepsy
epilepsy genetics
intellectual disability
voltage-gated sodium channels
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
29
10
2018
revised:
07
03
2019
accepted:
07
03
2019
pubmed:
11
4
2019
medline:
28
4
2020
entrez:
11
4
2019
Statut:
ppublish
Résumé
Pathogenic variants in SCN8A have been associated with a wide spectrum of epilepsy phenotypes, ranging from benign familial infantile seizures (BFIS) to epileptic encephalopathies with variable severity. Furthermore, a few patients with intellectual disability (ID) or movement disorders without epilepsy have been reported. The vast majority of the published SCN8A patients suffer from severe developmental and epileptic encephalopathy (DEE). In this study, we aimed to provide further insight on the spectrum of milder SCN8A-related epilepsies. A cohort of 1095 patients were screened using a next generation sequencing panel. Further patients were ascertained from a network of epilepsy genetics clinics. Patients with severe DEE and BFIS were excluded from the study. We found 36 probands who presented with an SCN8A-related epilepsy and normal intellect (33%) or mild (61%) to moderate ID (6%). All patients presented with epilepsy between age 1.5 months and 7 years (mean = 13.6 months), and 58% of these became seizure-free, two-thirds on monotherapy. Neurological disturbances included ataxia (28%) and hypotonia (19%) as the most prominent features. Interictal electroencephalogram was normal in 41%. Several recurrent variants were observed, including Ile763Val, Val891Met, Gly1475Arg, Gly1483Lys, Phe1588Leu, Arg1617Gln, Ala1650Val/Thr, Arg1872Gln, and Asn1877Ser. With this study, we explore the electroclinical features of an intermediate SCN8A-related epilepsy with mild cognitive impairment, which is for the majority a treatable epilepsy.
Substances chimiques
Anticonvulsants
0
NAV1.6 Voltage-Gated Sodium Channel
0
SCN8A protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
830-844Informations de copyright
Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.